Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload
Clinical trial NCT00560820 · COMPLETED
Trial details
- NCT number
- NCT00560820
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2012-04-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.